Trade tensions sink biotech shares as markets skid

While biopharma products have largely escaped Beijing and Washington’s tariff lists, biotech indexes were dragged down with the rest of the U.S. market Monday as the U.S. and China escalated their trade war. But industry observers do not expect the latest turmoil to derail the progress of IP reform in China.

The Chinese

Read the full 525 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE